[Vancomycin resistance in Gram-positive bacteria].
作者信息
Fernández-Roblas R, Soriano F
出版信息
Enferm Infecc Microbiol Clin. 1991 Feb;9(2):69-71.
PMID:1854852
Abstract
摘要
相似文献
1
[Vancomycin resistance in Gram-positive bacteria].[革兰氏阳性菌中的万古霉素耐药性]
Enferm Infecc Microbiol Clin. 1991 Feb;9(2):69-71.
2
R-factors in gram-positive and gram-negative aerobic bacteria selected by antimicrobial therapy.通过抗菌治疗选择的革兰氏阳性和革兰氏阴性需氧菌中的R因子。
Scand J Infect Dis Suppl. 1986;49:46-55.
3
[Bacterial resistance to vancomycin and other glycopeptide antibiotics: an emerging threat].
Postepy Biochem. 1999;45(2):122-36.
4
Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control.固有耐万古霉素革兰氏阳性菌：临床相关性及对感染控制的影响
J Hosp Infect. 1999 Aug;42(4):275-82. doi: 10.1053/jhin.1998.0605.
5
Vancomycin. A new old agent.万古霉素。一种新的老药。
Infect Dis Clin North Am. 1989 Sep;3(3):641-51.
6
Glycopeptide and lipoglycopeptide antibiotics.糖肽类和脂糖肽类抗生素。
Chem Rev. 2005 Feb;105(2):425-48. doi: 10.1021/cr030103a.
7
Vancomycin resistance: decoding the molecular logic.万古霉素耐药性：解读分子逻辑
Science. 1993 Jul 16;261(5119):308-9. doi: 10.1126/science.8392747.
8
Glycopeptide resistance in gram-positive bacteria: from black and white to shades of grey.
J Med Microbiol. 1994 Jun;40(6):375-8. doi: 10.1099/00222615-40-6-375.
9
Antibiotic resistance: how it arises, the current position and strategies for the future.抗生素耐药性：其产生方式、现状及未来策略
Nurs Times. 2009;105(36):20-3.
10
Vancomycin resistance: are there better glycopeptides coming?万古霉素耐药性：会有更好的糖肽类药物出现吗？
Expert Rev Anti Infect Ther. 2008 Dec;6(6):917-28. doi: 10.1586/14787210.6.6.917.
Zotero 插件